Delhi Declares Leprosy Notifiable Disease
Analysis based on 9 articles · First reported May 01, 2026 · Last updated May 01, 2026
The decision by India — Delhi to make leprosy a notifiable disease is a positive development for public health, potentially leading to better disease management and reduced transmission. This could indirectly benefit healthcare and pharmaceutical companies involved in diagnostics and Multi-Drug Therapy (MDT) in India, though the direct financial impact is likely minimal.
The India — Delhi government is set to declare leprosy a notifiable disease under the India — Delhi Epidemic Diseases Act. This move, led by Chief Minister Rekha Gupta and supported by Health Minister Pankaj Kumar Singh, aims to strengthen surveillance, ensure early detection, and improve treatment compliance. Once approved, all government and private healthcare providers in India — Delhi will be mandated to report new leprosy cases to the District Leprosy Officer. This initiative aligns India — Delhi with other Indian states like India — Tamil Nadu, India — Maharashtra, India — Karnataka, and India — West Bengal, which have already implemented similar measures. Despite India achieving leprosy elimination at a national level in 2005, the country still accounts for approximately 59% of global annual new leprosy cases, with a significant portion going unreported by private facilities. The World Health Organization has also suggested mandatory notification for leprosy in India to aid in early detection, reduce disability risk, enhance surveillance, prevent transmission, and reduce stigma.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard